Skip to main content
April 28, 2021

For the first time, the FDA may fine a drug maker for failing to post clinical trial results

Christopher Morten
Engelberg Center on Innovation Law & Policy 139 MacDougal Street Room 408, New York, NY 10012 engelberg.center@nyu.edu @nyuengelberg